Operating Lease, Right-of-Use Asset of ELITE PHARMACEUTICALS INC /NV/ from 02 Apr 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Apr 2019 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $1,651,592, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,651,592 -$459,325 -22% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 $1,770,693 -$318,331 -15% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 $1,886,899 -$335,273 -15% 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 $2,000,284 -$354,917 -15% 31 Mar 2025 10-Q 17 Feb 2026 2026 Q3
Q4 2024 $2,110,917 +$2,084,686 +7947% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q3
Q3 2024 $2,089,024 +$2,087,125 +109907% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q2
Q2 2024 $2,222,172 +$2,214,644 +29419% 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q1 2024 $2,355,201 +$2,342,139 +17931% 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 $26,231 +$7,729 +42% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 $1,899 -$21,951 -92% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q2
Q2 2023 $7,528 -$973,343 -99% 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
Q1 2023 $13,062 -$1,018,822 -99% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 $18,502 -$1,063,666 -98% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 $23,850 -$1,117,664 -98% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 $980,871 -$219,073 -18% 30 Jun 2022 10-Q 15 Aug 2022 2023 Q1
Q1 2022 $1,031,884 +$817,210 +381% 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 $1,082,168 +$869,783 +410% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 $1,141,514 +$878,059 +333% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 $1,199,944 +$886,194 +282% 30 Jun 2021 10-Q 16 Aug 2021 2022 Q1
Q1 2021 $214,674 -$148,608 -41% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 $212,385 -$199,678 -48% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $263,455 -$196,659 -43% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 $313,750 -$193,702 -38% 30 Jun 2020 10-Q 14 Aug 2020 2021 Q1
Q1 2020 $363,282 -$190,806 -34% 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 $412,063 31 Dec 2019 10-Q 10 Feb 2020 2020 Q3
Q3 2019 $460,114 30 Sep 2019 10-Q 12 Nov 2019 2020 Q2
Q2 2019 $507,452 30 Jun 2019 10-Q 09 Aug 2019 2020 Q1
Q1 2019 $554,088 02 Apr 2019 10-Q 09 Aug 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.